KalVista Pharmaceuticals (KALV) Q4 2022 Earnings

9MarConfirmed
Jul 22
Sep 22
Dec 22
Q4 2022
-1.09
-0.98
-0.86
-0.75

Details

Expected EPS
-0.98
Actual EPS
-0.75
Surprise EPS
0.23
Surprise Percent
+23.47%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.75 per share for Q4 2022.

0 Comments

Share your thoughts